{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:49:31Z","timestamp":1789670971084,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH\/NIBIB","award":["EB006369"],"award-info":[{"award-number":["EB006369"]}]},{"name":"NIH\/NIAID","award":["AI0680003"],"award-info":[{"award-number":["AI0680003"]}]},{"name":"NIH\/NIAID","award":["AI093772"],"award-info":[{"award-number":["AI093772"]}]},{"name":"NIH\/NIAID","award":["AI087782"],"award-info":[{"award-number":["AI087782"]}]},{"name":"NIH\/NIAID","award":["AI105170"],"award-info":[{"award-number":["AI105170"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jconrel.2013.04.016","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T16:32:21Z","timestamp":1367339541000},"page":"579-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles"],"prefix":"10.1016","volume":"172","author":[{"given":"Yeu-Chun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Goon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Compans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Prausnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.04.016_bb0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0010","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0015","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/428952","article-title":"Vaccination strategies for an influenza pandemic","volume":"191","author":"Schwartz","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","article-title":"Development of effective vaccines against pandemic influenza","volume":"24","author":"Subbarao","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic","volume":"442","author":"Ferguson","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0030","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: the challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0035","doi-asserted-by":"crossref","first-page":"D65","DOI":"10.1016\/j.vaccine.2009.08.038","article-title":"Influenza vaccines","volume":"27","author":"Ellebedy","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0040","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2011.12.098","article-title":"Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine","volume":"30","author":"Reed","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.micinf.2010.01.001","article-title":"Research and development of universal influenza vaccines","volume":"12","author":"Du","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0050","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0055","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3201\/eid0805.010476","article-title":"DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice","volume":"8","author":"Epstein","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0060","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.micinf.2008.07.002","article-title":"Heterosubtypic immunity to influenza A virus: where do we stand?","volume":"10","author":"Grebe","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0065","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/14760584.2.2.253","article-title":"Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin","volume":"2","author":"Glenn","year":"2003","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0085","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2009.10.013","article-title":"Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity","volume":"142","author":"Kim","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0095","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1128\/JVI.01849-09","article-title":"Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization","volume":"84","author":"Quan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/CVI.00435-10","article-title":"Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity","volume":"18","author":"Weldon","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11095-010-0134-6","article-title":"Stability kinetics of influenza vaccine coated onto microneedles during drying and storage","volume":"28","author":"Kim","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0115","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1208\/s12249-010-9471-3","article-title":"Formulation of microneedles coated with influenza virus-like particle vaccine","volume":"11","author":"Kim","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/gt.2010.22","article-title":"Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine","volume":"17","author":"Gill","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejpb.2012.03.010","article-title":"Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch","volume":"81","author":"Kim","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0130","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/mt.2012.69","article-title":"DNA vaccination in the skin using microneedles improves protection against influenza","volume":"20","author":"Song","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0135","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/bip.360020608","article-title":"Viscosity study of DNA","volume":"2","author":"Scruggs","year":"1964","journal-title":"Biopolymers"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0140","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/js980077+","article-title":"A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle","volume":"87","author":"Labhasetwar","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biomaterials.2005.06.015","article-title":"Fabrication, characterization, and biological assessment of multilayered DNA-coatings for biomaterial purposes","volume":"27","author":"van den Beucken","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0150","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1016\/j.vaccine.2009.08.108","article-title":"Improved influenza vaccination in the skin using vaccine coated-microneedles","volume":"27","author":"Kim","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.173.1.550","article-title":"The hybrid cytomegalovirus enhancer\/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines","volume":"173","author":"Garg","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2006.10.017","article-title":"Coated microneedles for transdermal delivery","volume":"117","author":"Gill","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0165","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus","volume":"81","author":"Quan","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0170","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1128\/jvi.69.3.1895-1902.1995","article-title":"Bone-marrow is a major site of long-term antibody-production after acute viral-infection","volume":"69","author":"Slifka","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0175","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/649228","article-title":"Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles","volume":"201","author":"Kim","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0180","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/infdis\/145.3.320","article-title":"Evaluation of live and inactivated influenza A virus vaccines in a mouse model","volume":"145","author":"Armerding","year":"1982","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0185","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.1192517","article-title":"Induction of broadly neutralizing H1N1 influenza antibodies by vaccination","volume":"329","author":"Wei","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0195","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.vaccine.2008.04.073","article-title":"Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2010.05.034","article-title":"Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles","volume":"405","author":"Song","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0205","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J. Hygiene"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1750-2659.2008.00060.x","article-title":"Improving seasonal and pandemic influenza vaccines","volume":"2","author":"Saville","year":"2008","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0215","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine","volume":"27","author":"Fiers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0220","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2010.07.125","article-title":"Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles","volume":"147","author":"Quan","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0225","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","article-title":"Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults","volume":"27","author":"Van Damme","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0230","doi-asserted-by":"crossref","first-page":"e7152","DOI":"10.1371\/journal.pone.0007152","article-title":"Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin","volume":"4","author":"Quan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2013.04.016_bb0235","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.158.5.2278","article-title":"Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization","volume":"158","author":"Feltquate","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.04.016_bb0240","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1473-3099(11)70240-7","article-title":"DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials","volume":"11","author":"Ledgerwood","year":"2011","journal-title":"Lancet Infect. Dis."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913002356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913002356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:30:50Z","timestamp":1759159850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913002356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0168365913002356"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.04.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}